A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT05620823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of Povorcitinib (INCB054707) in participants with moderate to severe Hidradenitis Suppurativa (HS) over a 12-week placebo controlled period, followed by a 42-week extension period.
Study identification
- NCT ID
- NCT05620823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 608 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2022
- Primary completion
- Feb 2, 2025
- Completion
- Dec 22, 2025
- Last update posted
- Feb 9, 2026
2022 – 2025
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site US303 | Phoenix | Arizona | 85006 | — |
| Investigative Site US335 | Arkansas City | Arkansas | 72758 | — |
| Investigative Site US307 | Fort Smith | Arkansas | 72916 | — |
| Investigative Site US315 | Laguna Niguel | California | 92677 | — |
| Investigative Site US326 | Los Angeles | California | 90045 | — |
| Investigative Site US323 | San Francisco | California | 94118 | — |
| Investigative Site US306 | Boca Raton | Florida | 33486 | — |
| Investigative Site US320 | Boca Raton | Florida | 33486 | — |
| Investigative Site US317 | Hialeah | Florida | 33012-3618 | — |
| Investigative Site US338 | Margate | Florida | 33063 | — |
| Investigative Site US321 | North Miami Beach | Florida | 33162-4708 | — |
| Investigative Site US316 | Orlando | Florida | 32819 | — |
| Investigative Site US328 | Tampa | Florida | 33612 | — |
| Investigative Site US336 | Tampa | Florida | 33613 | — |
| Investigative Site US311 | Marietta | Georgia | 30060-1047 | — |
| Investigative Site US327 | Chicago | Illinois | 60612 | — |
| Investigative Site US319 | Skokie | Illinois | 60077 | — |
| Investigative Site US337 | Indianapolis | Indiana | 46250 | — |
| Investigative Site US341 | Bowling Green | Kentucky | 42103 | — |
| Investigative Site US334 | Metairie | Louisiana | 70006 | — |
| Investigative Site US333 | Baltimore | Maryland | 21287 | — |
| Investigative Site US325 | Columbia | Maryland | 21045 | — |
| Investigative Site US318 | Beverly | Massachusetts | 01915 | — |
| Investigative Site US304 | Boston | Massachusetts | 02215 | — |
| Investigative Site US310 | Brighton | Massachusetts | 02135 | — |
| Investigative Site US302 | St Louis | Missouri | 63110 | — |
| Investigative Site US331 | Albuquerque | New Mexico | 87102 | — |
| Investigative Site US324 | Kew Gardens | New York | 11415 | — |
| Investigative Site US339 | Bexley | Ohio | 43209 | — |
| Investigative Site US330 | Boardman | Ohio | 44512 | — |
| Investigative Site US314 | Cincinnati | Ohio | 45219 | — |
| Investigative Site US312 | Cleveland | Ohio | 44106 | — |
| Investigative Site US301 | Portland | Oregon | 97223 | — |
| Investigative Site US340 | Bellaire | Texas | 77401 | — |
| Investigative Site US300 | Plano | Texas | 75025 | — |
| Investigative Site US313 | Norfolk | Virginia | 23502 | — |
| Investigative Site US308 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05620823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2026 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05620823 live on ClinicalTrials.gov.